• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症各阶段日常生活技能、认知与现实功能之间的关联;一项使用精神分裂症认知评定量表日文版的研究。

Associations between daily living skills, cognition, and real-world functioning across stages of schizophrenia; a study with the Schizophrenia Cognition Rating Scale Japanese version.

作者信息

Higuchi Yuko, Sumiyoshi Tomiki, Seo Tomonori, Suga Motomu, Takahashi Tsutomu, Nishiyama Shimako, Komori Yuko, Kasai Kiyoto, Suzuki Michio

机构信息

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan.

Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Japan.

出版信息

Schizophr Res Cogn. 2017 Feb 22;7:13-18. doi: 10.1016/j.scog.2017.01.001. eCollection 2017 Mar.

DOI:10.1016/j.scog.2017.01.001
PMID:28740824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5514300/
Abstract

Cognitive function is impaired in patients with schizophrenia-spectrum disorders, even in their prodromal stages. Specifically, the assessment of cognitive abilities related to daily-living functioning, or functional capacity, is important to predict long-term outcome. In this study, we sought to determine the validity of the Schizophrenia Cognition Rating Scale (SCoRS) Japanese version, an interview-based measure of cognition relevant to functional capacity (i.e. co-primary measure). For this purpose, we examined the relationship of SCoRS scores with performance on the Brief Assessment of Cognition in Schizophrenia (BACS) Japanese version, a standard neuropsychological test battery, and the Social and Occupational Functioning Assessment Scale (SOFAS), an interview-based social function scale. Subjects for this study (n = 294) included 38 patients with first episode schizophrenia (FES), 135 with chronic schizophrenia (CS), 102 with at-risk mental state (ARMS) and 19 with other psychiatric disorders with psychosis. SCoRS scores showed a significant relationship with SOFAS scores for the entire subjects. Also, performance on the BACS was significantly correlated with SCoRS scores. These associations were also noted within each diagnosis (FES, CS, ARMS). These results indicate the utility of SCoRS as a measure of functional capacity that is associated both with cognitive function and real-world functional outcome in subjects with schizophrenia-spectrum disorders.

摘要

精神分裂症谱系障碍患者即使在前驱期认知功能也会受损。具体而言,评估与日常生活功能或功能能力相关的认知能力对于预测长期预后很重要。在本研究中,我们试图确定精神分裂症认知评定量表(SCoRS)日语版的有效性,这是一种基于访谈的与功能能力相关的认知测量方法(即共同主要测量方法)。为此,我们研究了SCoRS分数与精神分裂症认知简短评估(BACS)日语版(一种标准神经心理测试组合)的表现以及社会和职业功能评估量表(SOFAS)(一种基于访谈的社会功能量表)之间的关系。本研究的受试者(n = 294)包括38例首发精神分裂症(FES)患者、135例慢性精神分裂症(CS)患者、102例有精神病风险状态(ARMS)患者和19例患有其他伴有精神病性症状的精神障碍患者。对于所有受试者,SCoRS分数与SOFAS分数显示出显著关系。此外,BACS的表现与SCoRS分数显著相关。在每个诊断组(FES、CS、ARMS)中也观察到了这些关联。这些结果表明SCoRS作为一种功能能力测量方法的效用,它与精神分裂症谱系障碍患者的认知功能和现实世界功能结局均相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf01/5514300/564a9c11237e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf01/5514300/d9a2c610aa52/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf01/5514300/564a9c11237e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf01/5514300/d9a2c610aa52/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf01/5514300/564a9c11237e/gr2.jpg

相似文献

1
Associations between daily living skills, cognition, and real-world functioning across stages of schizophrenia; a study with the Schizophrenia Cognition Rating Scale Japanese version.精神分裂症各阶段日常生活技能、认知与现实功能之间的关联;一项使用精神分裂症认知评定量表日文版的研究。
Schizophr Res Cogn. 2017 Feb 22;7:13-18. doi: 10.1016/j.scog.2017.01.001. eCollection 2017 Mar.
2
The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.精神分裂症认知评定量表:一种基于访谈的评估及其与认知、现实世界功能和功能能力的关系。
Am J Psychiatry. 2006 Mar;163(3):426-32. doi: 10.1176/appi.ajp.163.3.426.
3
Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia.验证精神分裂症认知评定量表(SCoRS)的波斯语版本在精神分裂症患者中的适用性。
Asian J Psychiatr. 2017 Jun;27:12-15. doi: 10.1016/j.ajp.2017.02.007. Epub 2017 Feb 14.
4
Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale.《精神分裂症认知评定量表》中文版的效度验证
Psychiatry Investig. 2022 Jul;19(7):511-518. doi: 10.30773/pi.2021.0322. Epub 2022 Jul 21.
5
Olfactory deficits in individuals at risk for psychosis and patients with schizophrenia: relationship with socio-cognitive functions and symptom severity.嗅觉缺陷在精神病风险个体和精神分裂症患者中:与社会认知功能和症状严重程度的关系。
Eur Arch Psychiatry Clin Neurosci. 2018 Oct;268(7):689-698. doi: 10.1007/s00406-017-0845-3. Epub 2017 Oct 25.
6
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care.基于访谈的精神分裂症认知评估:精神分裂症认知评定量表(SCoRS)在疾病不同阶段和护理环境中的适用性。
Schizophr Res. 2013 May;146(1-3):217-23. doi: 10.1016/j.schres.2013.02.035. Epub 2013 Mar 17.
7
Analysis of polyunsaturated fatty acids in antipsychotic-free individuals with at-risk mental state and patients with first-episode schizophrenia.有精神病风险的未服用抗精神病药物个体及首发精神分裂症患者的多不饱和脂肪酸分析
Front Psychiatry. 2023 Jul 26;14:1188452. doi: 10.3389/fpsyt.2023.1188452. eCollection 2023.
8
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].[一种用于评估精神分裂症认知功能的新工具的价值:精神分裂症认知功能简短评估量表(BACS)]
Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9.
9
[Schizophrenia Cognition Rating Scale Japanese version (SCoRS-J) as a co-primary measure assessing cognitive function in schizophrenia].[作为评估精神分裂症认知功能的共同主要指标的精神分裂症认知评定量表日语版(SCoRS-J)]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Nov;31(5-6):259-62.
10
Subjectively-assessed cognitive impairment and neurocognition associations in schizophrenia inpatients.精神分裂症住院患者主观评估的认知障碍与神经认知的关联
Schizophr Res Cogn. 2021 Oct 2;27:100218. doi: 10.1016/j.scog.2021.100218. eCollection 2022 Mar.

引用本文的文献

1
Cognitive Remediation for Psychosis in Virtual Reality (ThinkTactic VR): Qualitative, Iterative, and User-Centered Codevelopment Study.虚拟现实中针对精神病的认知康复(ThinkTactic VR):定性、迭代和以用户为中心的共同开发研究
JMIR Ment Health. 2025 Jul 11;12:e69359. doi: 10.2196/69359.
2
Assessing the inter-rater reliability of the Schizophrenia Cognition Rating Scale: a non-interventional quantitative study.评估精神分裂症认知评定量表的评分者间信度:一项非干预性定量研究。
Schizophrenia (Heidelb). 2025 Apr 28;11(1):71. doi: 10.1038/s41537-025-00619-9.
3
Research hotspots and trends in transcranial magnetic stimulation for cognitive impairment: A bibliometric analysis from 2014 to 2023.

本文引用的文献

1
Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS.等百分位关联量表测量功能和症状:检验 GAF、SOFAS、CGI-S 和 PANSS。
Eur Neuropsychopharmacol. 2014 Nov;24(11):1767-72. doi: 10.1016/j.euroneuro.2014.08.009. Epub 2014 Aug 20.
2
Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale.精神分裂症认知评定量表的信度、效度及治疗敏感性
Eur Neuropsychopharmacol. 2015 Feb;25(2):176-84. doi: 10.1016/j.euroneuro.2014.06.009. Epub 2014 Jun 28.
3
Mismatch negativity and p3a/reorienting complex in subjects with schizophrenia or at-risk mental state.
经颅磁刺激治疗认知障碍的研究热点与趋势:2014年至2023年的文献计量分析
World J Psychiatry. 2024 Oct 19;14(10):1592-1604. doi: 10.5498/wjp.v14.i10.1592.
4
Resting-state electroencephalogram in drug-free subjects with at-risk mental states who later developed psychosis: a low-resolution electromagnetic tomography analysis.后期发展为精神病的处于高危精神状态的未用药受试者的静息态脑电图:一种低分辨率电磁断层扫描分析。
Front Hum Neurosci. 2024 Aug 27;18:1449820. doi: 10.3389/fnhum.2024.1449820. eCollection 2024.
5
Location-based differences in cognition and functional capacity: Consistent levels of impairment in participants with schizophrenia compared to healthy controls.基于位置的认知和功能能力差异:与健康对照组相比,精神分裂症患者的损伤程度一致。
Psychiatry Res. 2024 Oct;340:116121. doi: 10.1016/j.psychres.2024.116121. Epub 2024 Aug 13.
6
Relationships between erythrocyte membrane mono- and poly- unsaturated fatty acid composition and clinical/cognitive indices in antipsychotic-free schizophrenia patients.未服用抗精神病药物的精神分裂症患者红细胞膜单不饱和脂肪酸和多不饱和脂肪酸组成与临床/认知指标之间的关系。
Front Psychiatry. 2024 Apr 23;15:1361997. doi: 10.3389/fpsyt.2024.1361997. eCollection 2024.
7
Analysis of polyunsaturated fatty acids in antipsychotic-free individuals with at-risk mental state and patients with first-episode schizophrenia.有精神病风险的未服用抗精神病药物个体及首发精神分裂症患者的多不饱和脂肪酸分析
Front Psychiatry. 2023 Jul 26;14:1188452. doi: 10.3389/fpsyt.2023.1188452. eCollection 2023.
8
Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes.精神分裂症的临床结局评估工具:一项以患者报告结局的潜力为重点的范围性文献综述
Innov Clin Neurosci. 2023 Spring;20(4-6):14-33.
9
European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.欧洲精神病学协会关于精神分裂症认知障碍评估的指南。
Eur Psychiatry. 2022 Sep 5;65(1):e58. doi: 10.1192/j.eurpsy.2022.2316.
10
Risk factors for readmission in schizophrenia treated with combined psychoeducation and standard therapy.精神分裂症患者接受联合心理教育和标准治疗后的再入院风险因素。
Neuropsychopharmacol Rep. 2022 Mar;42(1):77-83. doi: 10.1002/npr2.12229. Epub 2022 Jan 26.
精神分裂症或处于高危精神状态的受试者的失配负波和P3a/重新定向复合体
Front Behav Neurosci. 2014 May 13;8:172. doi: 10.3389/fnbeh.2014.00172. eCollection 2014.
4
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care.基于访谈的精神分裂症认知评估:精神分裂症认知评定量表(SCoRS)在疾病不同阶段和护理环境中的适用性。
Schizophr Res. 2013 May;146(1-3):217-23. doi: 10.1016/j.schres.2013.02.035. Epub 2013 Mar 17.
5
Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.错配负波与认知表现对有高危精神状态的个体发生精神病的预测作用。
PLoS One. 2013;8(1):e54080. doi: 10.1371/journal.pone.0054080. Epub 2013 Jan 17.
6
[Schizophrenia Cognition Rating Scale Japanese version (SCoRS-J) as a co-primary measure assessing cognitive function in schizophrenia].[作为评估精神分裂症认知功能的共同主要指标的精神分裂症认知评定量表日语版(SCoRS-J)]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Nov;31(5-6):259-62.
7
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia.评估精神分裂症认知增强临床试验中具有临床意义的测量指标。
Am J Psychiatry. 2011 Apr;168(4):400-7. doi: 10.1176/appi.ajp.2010.10030414. Epub 2011 Feb 1.
8
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.在一项随机、双盲的比较研究中,对卢拉西酮和齐拉西酮的认知变化进行基于表现和访谈的评估。
Schizophr Res. 2011 Apr;127(1-3):188-94. doi: 10.1016/j.schres.2011.01.004. Epub 2011 Jan 31.
9
The Schizophrenia Cognition Rating Scale: validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia.精神分裂症认知评定量表:一种基于访谈的亚洲精神分裂症患者认知功能评估工具的验证。
Psychiatry Res. 2010 Jun 30;178(1):33-8. doi: 10.1016/j.psychres.2010.03.020. Epub 2010 May 6.
10
Brief assessment of cognition in schizophrenia: validation of the Japanese version.精神分裂症认知功能的简要评估:日文版的验证
Psychiatry Clin Neurosci. 2007 Dec;61(6):602-9. doi: 10.1111/j.1440-1819.2007.01725.x.